推薦產品
用途
sufficient for ≤1,000 tests
品質等級
製造商／商標名
Roche
技術
ELISA: suitable
檢測方法
chemiluminescent
運輸包裝
wet ice
儲存溫度
2-8°C
一般說明
通过测量DNA合成期间的BrdU掺入而定量细胞增殖的化学发光免疫分析方法： [3H]-胸苷掺入测定的非放射性替代方法。
特異性
抗体结合物与胸苷类似物5-溴-2′-脱氧尿苷（BrdU）以及掺入DNA的BrdU反应。为结合掺入DNA的BrdU，必须使BrdU标记的DNA变性。抗体不与胸苷、尿苷或DNA等任何内源性细胞组分发生交叉反应。
應用
细胞增殖ELISA，BrdU（化学发光法）属于第二代改良型DNA合成检测试剂盒。它是一个精确、快速且简单的非放射性替代方法，通过测量复制（循环）细胞中DNA合成期间的BrdU掺入而定量细胞增殖。因此，细胞增殖ELISA可用于许多不同的 体外 细胞系统。例如：
- 检测和定量由生长因子和细胞因子诱导的细胞增殖
- 在环境和生物医学研究以及食品、化妆品和制药行业中，用于检测各种化合物细胞增殖的抑制或刺激作用
- 测量由有丝分裂原或抗原刺激的淋巴细胞的免疫反应性
- 在医学研究中分析肿瘤细胞对不同细胞抑制剂的化疗敏感性
细胞增殖ELISA，BrdU（化学发光法）已用于：
- ReN和原代星形胶质细胞的溴脱氧尿苷(BrdU)增殖检测
- 通过BrdU掺入实验分析伊马替尼对神经母细胞瘤细胞增殖的影响
- 通过BrdU掺入实验研究帕博西尼对胰腺病患原代细胞系中细胞周期的抑制作用
包裝
1个试剂盒包含7种组分。
成分
- BrdU 标记试剂 1,000倍 浓度
- FixDenat
- 抗-BrdU-POD 4.抗体稀释溶液
- PBS 洗涤缓冲溶液, 10倍浓度
- 底物组分 A
- 底物组分 B
其他說明
仅用于生命科学研究。不可用于诊断。
僅套裝組件
產品號碼
描述
- BrdU Labeling Reagent
- FixDenat ready-to-use
- Anti-BrdU-peroxidase antibody
- Antibody Dilution Solution ready-to-use
- ready-to-use 10x concentrated
- Substrate Component A
- Substrate Component B
訊號詞
Danger
危險分類
Eye Irrit. 2 - Flam. Liq. 2 - Muta. 1B - Skin Sens. 1
儲存類別代碼
3 - Flammable liquids
水污染物質分類（WGK）
WGK 1
客戶也查看了
Mette Lorenzen et al.
Cancers, 12(6) (2020-05-30)
Luteinizing hormone/choriogonadotropin receptor (LHCGR) regulates gonadal testosterone production and recent studies have suggested a growth-regulatory role in somatic cancers. Here, we established that LHCGR is expressed in a fraction of seminoma cells and germ cell neoplasia in situ (GCNIS), and
Diego S D'Astolfo et al.
Cell, 161(3), 674-690 (2015-04-25)
Modulation of protein function is used to intervene in cellular processes but is often done indirectly by means of introducing DNA or mRNA encoding the effector protein. Thus far, direct intracellular delivery of proteins has remained challenging. We developed a
Min Wu et al.
Frontiers in endocrinology, 13, 775278-775278 (2022-05-10)
This study aims to identify reliable prognostic biomarkers for differentiated thyroid cancer (DTC) based on glycolysis-related genes (GRGs), and to construct a glycolysis-related gene model for predicting the prognosis of DTC patients. We retrospectively analyzed the transcriptomic profiles and clinical
Xiao-Feng Wang et al.
Molecular medicine reports, 12(4), 5917-5923 (2015-08-25)
Epirubicin, an anthracycline derivative, is one of the main line treatments for brain tumors. The aim of the present study was to verify that epirubicin alters the growth and morphological characteristics of U‑87 glioma cells. In the present study, the
Valerio Ciccone et al.
Oncotarget, 9(17), 13353-13365 (2018-03-24)
Nitric oxide (NO) exerts conflicting effect on tumor growth and progression, depending on its concentration. We aimed to characterize the anti-cancer activity of a new NO donor, Ni(SalPipNONO) belonging to the class of metal-nonoates, in epithelial derived tumor cells, finally
文章
The NTP transporter allows dUTPs to enter live cells and is an alternative to BrdU/EdU cell proliferation assays used to measure cell cycle dynamics in real-time.
Cell based assays for cell proliferation (BrdU, MTT, WST1), cell viability and cytotoxicity experiments for applications in cancer, neuroscience and stem cell research.
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務